World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
26122
World Ranking
15087
National Ranking
7618

Overview

Hugo R. Rosen is affiliated with the University of Southern California in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a particular focus on Immunology, Epidemiology, and Hepatology.

The scientist's work centers on topics such as Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, Immune Cell Function and Interaction, Renal Transplantation Outcomes and Treatments, T-cell and B-cell Immunology, and SARS-CoV-2 and COVID-19 Research.

Frequent publication venues for Hugo R. Rosen include:

  • Hepatology
  • Zenodo (CERN European Organization for Nuclear Research)
  • Genes and Immunity
  • Hepatology Communications
  • Cellular and Molecular Gastroenterology and Hepatology

Recent papers authored or co-authored by the scientist include:

  • American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease, 2021, Hepatology
  • Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort, 2021, Hepatology Communications
  • Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System, 2020, Cellular and Molecular Gastroenterology and Hepatology
  • In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood, 2021, Hepatology
  • Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease, 2021, iScience

Hugo R. Rosen collaborates frequently with other researchers, including Lucy Golden-Mason, Ana C. Maretti-Mira, Rachel H. McMahan, David J. Orlicky, and Ana Valencia.

Best Publications

  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

    George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson

  • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

    David L. Thomas;Chloe L Thio;Maureen P. Martin;Ying Qi

  • Milk Thistle ( Silybum marianum ) for the Therapy of Liver Disease

    Kenneth Flora;Martin Hahn;Hugo Rosen;Kent Benner

  • Fructose and sugar: A major mediator of non-alcoholic fatty liver disease

    Thomas Jensen;Manal F. Abdelmalek;Shelby Sullivan;Kristen J. Nadeau

  • An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection

    Roniel Cabrera;Zhengkun Tu;Yiling Xu;Roberto J. Firpi

  • Chronic Hepatitis C Infection

    Hugo R. Rosen

  • Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells

    Lucy Golden-Mason;Brent E. Palmer;Nasim Kassam;Lisa Townshend-Bulson

  • Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction

    Lucy Golden-Mason;Brent Palmer;Jared Klarquist;John A. Mengshol

  • NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS

    Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon

  • Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity

    Rachel H. McMahan;Lucy Golden-Mason;Michael I. Nishimura;Brian J. McMahon

  • Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

    Sufen Shang;Amelie Plymoth;Amelie Plymoth;Shaokui Ge;Ziding Feng

  • High‐fat and high‐sucrose (western) diet induces steatohepatitis that is dependent on fructokinase

    Takuji Ishimoto;Miguel A. Lanaspa;Christopher J. Rivard;Carlos A. Roncal‐Jimenez

  • Acute Hepatitis C in a Contemporary US Cohort: Modes of Acquisition and Factors Influencing Viral Clearance

    Chia C. Wang;Elizabeth Krantz;Jared Klarquist;Meighan Krows

  • Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0

    Ian M Gralnek;Ron D Hays;Ron D Hays;Amy Kilbourne;Hugo R Rosen

  • Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

    Priya Duggal;Chloe L. Thio;Genevieve L. Wojcik;James J. Goedert

  • Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species†

    Robert S. Tacke;Hai Chon Lee;Celeste Goh;Jeremy Courtney

  • Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.

    Rachel H. McMahan;Xiaoxin X. Wang;Lin Ling Cheng;Tibor Krisko

  • A model to predict survival following liver retransplantation

    Hugo R. Rosen;Joseph P. Madden;Paul Martin

  • A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection

    John A. Mengshol;Lucy Golden-Mason;Tomohiro Arikawa;Maxwell Smith

  • Immune evasion versus recovery after acute hepatitis C virus infection from a shared source

    Ian Tester;Susan Smyk-Pearson;Susan Smyk-Pearson;Ping Wang;Anne Wertheimer

Frequent Co-Authors

Lucy Golden-Mason
Lucy Golden-Mason University of Southern California
Christopher L. Corless
Christopher L. Corless Oregon Health & Science University
Raymond T. Chung
Raymond T. Chung Harvard University
David L. Thomas
David L. Thomas Johns Hopkins University
Sunwen Chou
Sunwen Chou Oregon Health & Science University
Georg M. Lauer
Georg M. Lauer Harvard University
Chloe L. Thio
Chloe L. Thio Johns Hopkins University
Michael I. Nishimura
Michael I. Nishimura Loyola University Chicago
Arthur Y. Kim
Arthur Y. Kim Harvard University
Brian R. Edlin
Brian R. Edlin National Development and Research Institutes

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but are exploring flexible options, online degrees offer a range of alternative healthcare pathways. For registered nurses aiming to further their careers or move into specialized roles, online programs can be a smart and affordable choice. Many universities now offer cheap np programs that provide advanced clinical training and leadership skills, opening doors to highly sought-after nurse practitioner roles.

For those seeking to take the next step, completing a bachelor's degree in nursing is more accessible than ever with the cheapest rn to bsn online programs and a wide range of options for the cheapest online rn to bsn programs. These programs help RNs transition into roles with greater responsibility and income potential.

For nursing professionals considering academia or leadership, doctorate in nursing education online programs provide an opportunity to contribute to education, research, and policy. Exploring these pathways means you don’t have to pause your career or relocate—online education supports your growth wherever you are.

Best Scientists Citing Hugo R. Rosen

Trending Scientists

Recently Published Articles